# Arthritis UK Arthritis UK is an Endowment / Foundation based in Chesterfield, United Kingdom. ## Overview - **Organization type:** Endowment / Foundation - **Headquarters:** Chesterfield, United Kingdom - **Region:** Europe - **Address:** Copeman House, St Mary's Gate, Chesterfield, S41 7TD, United Kingdom - **Founded:** 2018 - **Assets under management:** Undisclosed - **Website:** www.versusarthritis.org - **LinkedIn:** https://www.linkedin.com/company/arthritisuk ## Regulatory record - **Reports private funds:** No ## About Arthritis UK launched in 2018 as Versus Arthritis, the product of a merger between Arthritis Research UK and Arthritis Care—two legacy organizations with decades of history in British medical philanthropy. The charity adopted its current name in 2025, streamlining its public identity. Headquartered at Copeman House in Chesterfield, the organization is governed by a Board of Trustees chaired by Kate Tompkins, with Chief Executive Deborah Alsina MBE running day-to-day operations since her appointment in March 2022. The charity is a core member of both the Association of Medical Research Charities and the Richmond Group of Charities, a coalition of leading UK health and social care organizations. The portfolio splits between an endowed investment pool and direct programmatic grant-making. On the research side, Arthritis UK funds academic and clinical projects across the UK, targeting rheumatoid arthritis, osteoarthritis, and musculoskeletal pain mechanisms. A signature partnership is the Advanced Pain Discovery Platform, co-developed with UK Research and Innovation (UKRI), which backs translational science aimed at chronic pain treatment. The charity also co-funds with the Kennedy Trust for Rheumatology Research, a major Oxford-based biomedical funder. These collaborations place Arthritis UK in the center of UK rheumatology research infrastructure rather than at a passive grant-making remove. Its investment property holdings and the Maisie Lewis Fund augment its grant-making capacity. Team scale and precise assets-under-management are not publicly disclosed as standard practice for UK charitable foundations, though annual research expenditure runs in the tens of millions of pounds. The organization maintains commercial investment property in the UK alongside its research endowment. Deborah Alsina's appointment in March 2022 brought a seasoned charity-sector executive to the helm, succeeding a period of post-merger integration. HM Queen Camilla serves as Patron, providing institutional visibility that supports fundraising and advocacy efforts. The charity's governance structure separates its investment committee from its research strategy board, a common architecture for UK medical foundations. In 2025 the organization rebranded from Versus Arthritis to Arthritis UK, a move to sharpen public recognition after seven years operating under the post-merger name. Arthritis UK's structural differentiator is its dual role as a convener of UK-wide research consortia and a direct patient-support operation. Unlike foundations that simply write cheques to university labs, it co-designs research platforms with government funders like UKRI and co-invests alongside specialist rheumatology trusts, creating leverage on its endowment that a pure capital allocator cannot achieve. This operational posture makes it a node in UK musculoskeletal science rather than a passive funder, a distinction that shapes both its talent attraction to the board and its influence on national research priorities. ## Sectors - Healthcare Services ## People - Deborah Alsina MBE — Chief Executive Officer - Kate Tompkins — Chair of the Board of Trustees ## Questions ### How does Arthritis UK source its research partnerships? Arthritis UK co-designs research platforms with government funders and peer foundations rather than relying solely on open calls for proposals. Its Advanced Pain Discovery Platform, developed jointly with UK Research and Innovation (UKRI), is a flagship example of this proactive approach. The charity also maintains a long-standing co-funding relationship with the Kennedy Trust for Rheumatology Research, creating a network of pre-vetted academic and clinical partners. ### Where does Arthritis UK's funding come from? The charity's income derives from a mix of public donations, legacy gifts, and returns on its endowed investment portfolio. Its property holdings, including Copeman House in Chesterfield and additional commercial investment property in the UK, generate rental income that supports operations. The Maisie Lewis Fund, a named sub-fund within the charity, provides additional grant-making capacity. ### What is Arthritis UK's research focus? The charity funds research across the full spectrum of arthritis and musculoskeletal conditions, including rheumatoid arthritis, osteoarthritis, and chronic pain mechanisms. Its strategy emphasizes translational science that moves laboratory findings into clinical practice, with a particular concentration on pain management. Through its partnerships with UKRI and the Kennedy Trust, it has directed substantial funding toward the Advanced Pain Discovery Platform and related consortia. ### Is Arthritis UK a grant-making foundation or a research institute? Arthritis UK is a grant-making foundation that funds external researchers at UK universities and hospitals, not a research institute with its own laboratories. However, its approach is more hands-on than a passive grant-maker: it co-designs research platforms with partners like UKRI, co-funds alongside specialist trusts, and advocates for national research priorities. This bridges the gap between pure philanthropy and an operating research organization. ## Related profiles - [Versorgungswerk der Zahnärztekammer Westfalen-Lippe](https://altss.com/profile/versorgungswerk-der-zahn-rztekammer-westfalen-lippe) - [Vertex Financial Advisors](https://altss.com/profile/vertex-financial-advisors) --- Last updated: 2026-06-03T20:00:00.000Z Canonical page: https://altss.com/profile/versus-arthritis Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology